Sebastian Anastassiou
Investing in need-driven health tech founders
Sebastian Anastassiou
Investing in need-driven health tech founders
Barcelona, Catalonia
Overview
Work Experience
Principal, Head of Investments
2022 - Current
Investing in need-driven health tech founders building the future of information-driven healthcare.
Investment Manager
2021 - 2022
Associate
2020 - 2021
MBA Associate
2020 - 2020
Board Member
2024
Empowering providers with easy access to outside medical records and targeted clinical insights Driving better outcomes for patients.
Board Member
2022
Segmed partners with health systems and other medical providers to provide curated and anonymized data for medical AI companies to facilitate and accelerate algorithm development.
Board Observer
2021
Promptly is defined by this anxiety of fundamentally changing how health is perceived by patients and how healthcare is structured and delivered by providers.
Board Member
2021
EarlySight is developing a medical device to help doctors detect and treat eye diseases at an early-stage thanks to precise retinal imaging.
Board Observer
2020 - 2021
Board Member
2021
Contextflow's mission is o empower radiologists to complete their daily workload faster and with higher quality and cost-efficiency by delivering a unique and scalable AI backbone that fully integrates into clinical workflows.
Board Member
2022 - 2024
Formulator Ltd is a Finnish company providing a solution for mental health case formulations as a service to both individuals and professionals. Formulator has modelled research evidence and decades of clinical expertise behind a conversational agent. The individual’s dialogue with the agent produces a case formulation, MyTarina, that is shared with the clinician.
Board Member
2023 - 2024
Terapet's vision is that their innovative solutions will be an integral part of the next generation proton therapy - safer, more precise, faster and available for the wider public.
Board Observer
2020 - 2022
Replica Analytics develops unique technologies for generating privacy protective synthetic data that maintains the statistical properties of real data, enabling fast and effective access to high utility data while meeting regulatory obligations. The team has developed technology specific to the complexities of longitudinal health data. Replica was acquired by Aetion.
MBA Candidate 2021
2019 - 2021
- Concentration in Entrepreneurship & Innovation - VP of Startup & Entrepreneurship Club - Managing the Barcelona Technology Transfer Group (BTTG) program - Consultant for Healthcare startups